ER+/HER2+ Metastatic Breast Cancer
2 Pogledi
• 07/03/23
0
0
Ugraditi
administrator
Pretplatnici
Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.
Prikaži više
Komentari na Facebooku
SORT BY-
Najbolji komentari
-
Najnoviji komentari